Compounds > zoledronic acid
Page last updated: 2024-08-25

zoledronic acid and Mastocytosis, Systemic

zoledronic acid has been researched along with Mastocytosis, Systemic in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (50.00)29.6817
2010's2 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Adami, S; Biondan, M; Bonadonna, P; Gatti, D; Idolazzi, L; Orsolini, G; Rossini, M; Tripi, G; Viapiana, O; Zanotti, R1
Gehlen, M; Hinz, C; Lazarescu, AD; Maier, A; Pfeifer, M; Schmidt, N; Schwarz-Eywill, M; Weidemann, HF; Werner, M1
Brendel, C; Hamann, C; Hofbauer, LC; Krüger, A; Neubauer, A; Ramaswamy, A; Schnabel, M1
Andrada, E; Cánovas, V; Carrato, A; Guillén-Ponce, C; Guirado-Risueño, M; Martín Hidalgo, A; Molina, MA; Molina, MJ; Molina-Garrido, MJ; Mora, A; Pastor, E1

Other Studies

4 other study(ies) available for zoledronic acid and Mastocytosis, Systemic

ArticleYear
Zoledronic acid in osteoporosis secondary to mastocytosis.
    The American journal of medicine, 2014, Volume: 127, Issue:11

    Topics: Absorptiometry, Photon; Adult; Aged; Aged, 80 and over; Alkaline Phosphatase; Bone Density; Bone Density Conservation Agents; Collagen Type I; Diphosphonates; Female; Follow-Up Studies; Humans; Imidazoles; Infusions, Intravenous; Male; Mastocytosis, Systemic; Middle Aged; Osteoporosis; Peptides; Zoledronic Acid

2014
[Severe therapy refractive osteoporosis : A rare differential diagnosis].
    Zeitschrift fur Rheumatologie, 2016, Volume: 75, Issue:7

    Topics: Adult; Anti-Inflammatory Agents; Bone Density Conservation Agents; Chronic Disease; Diagnosis, Differential; Diphosphonates; Female; Humans; Imidazoles; Male; Mastocytosis, Systemic; Middle Aged; Osteoporosis; Rare Diseases; Treatment Failure; Treatment Outcome; Zoledronic Acid

2016
Multimodal therapy for vertebral involvement of systemic mastocytosis.
    Spine, 2009, Aug-01, Volume: 34, Issue:17

    Topics: Adult; Back Pain; Biomarkers; Biopsy; Bone Density; Bone Density Conservation Agents; Diphosphonates; Glucocorticoids; Histamine; Humans; Hypotension; Imidazoles; Male; Mast Cells; Mastocytosis, Systemic; Osteoporosis; Postoperative Complications; Prednisolone; Pressure; Proto-Oncogene Proteins c-kit; Spinal Fractures; Spine; Treatment Outcome; Vertebroplasty; Zoledronic Acid

2009
Multiple bone lesions resembling a metastatic origin. An unexpected diagnosis.
    Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2008, Volume: 10, Issue:4

    Topics: Aged; Anemia; Back Pain; Bone Density Conservation Agents; Bone Neoplasms; Diagnosis, Differential; Diphosphonates; Female; Humans; Hypertension; Imidazoles; Immunologic Factors; Interferon-alpha; Magnetic Resonance Imaging; Mastocytosis, Systemic; Osteolysis; Osteoporosis; Radionuclide Imaging; Zoledronic Acid

2008